Is Aslan Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: ASLN) stock is to Strong Buy ASLN stock.
Out of 2 analysts, 1 (50%) are recommending ASLN as a Strong Buy, 1 (50%) are recommending ASLN as a Buy, 0 (0%) are recommending ASLN as a Hold, 0 (0%) are recommending ASLN as a Sell, and 0 (0%) are recommending ASLN as a Strong Sell.
What is ASLN's forecast return on equity (ROE) for 2024-2027?
(NASDAQ: ASLN) forecast ROE is N/A, which is considered weak.
What is ASLN's Price Target?
According to 2 Wall Street analysts that have issued a 1 year ASLN price target, the average ASLN price target is $9.50, with the highest ASLN stock price forecast at $10.00 and the lowest ASLN stock price forecast at $9.00.
On average, Wall Street analysts predict that Aslan Pharmaceuticals's share price could reach $9.50 by Apr 23, 2025. The average Aslan Pharmaceuticals stock price prediction forecasts a potential upside of 1,925.59% from the current ASLN share price of $0.47.
What is ASLN's forecast return on assets (ROA) for 2024-2027?
(NASDAQ: ASLN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.